Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/134578
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Campo DC Valor Lengua/Idioma
dc.contributor.authorIglesias, Juan Manuel-
dc.contributor.authorHernández-García, Susana-
dc.contributor.authorPandiella, Atanasio-
dc.contributor.authorGarcía Martín, Ángel-
dc.date.accessioned2016-07-07T11:04:44Z-
dc.date.available2016-07-07T11:04:44Z-
dc.date.issued2014-
dc.identifierdoi: 10.3389/fonc.2014.00308-
dc.identifiere-issn: 2234-943X-
dc.identifier.citationFrontiers in Oncology 4: 308 (2014)-
dc.identifier.urihttp://hdl.handle.net/10261/134578-
dc.descriptionThis is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY).-- et al.-
dc.description.abstractThe striking similarity displayed at the mechanistic level between tumorigenesis and the generation of induced pluripotent stem cells and the fact that genes and pathways relevant for embryonic development are reactivated during tumor progression highlights the link between pluripotency and cancer. Based on these observations, we tested whether it is possible to use a pluripotency-associated transcriptional reporter, whose activation is driven by the SRR2 enhancer from the Sox2 gene promoter (named S4+ reporter), to isolate cancer stem cells (CSCs) from breast cancer cell lines. The S4+ pluripotency transcriptional reporter allows the isolation of cells with enhanced tumorigenic potential and its activation was switched on and offin the cell lines studied, reflecting a plastic cellular process. Microarray analysis comparing the populations in which the reporter construct is active versus inactive showed that positive cells expressed higher mRNA levels of cytokines (IL-8, IL-6, TNF) and genes (such as ATF3, SNAI2, and KLF6) previously related with the CSC phenotype in breast cancer.-
dc.description.sponsorshipThis work is supported by grants from Obra Social Kutxa, Gobierno Vasco (Saiotek program and Consejería de Educación PI2010-25), and Instituto de Salud Carlos III Acción Estratégica en Salud (PI2010-01035). Work in Atanasio Pandiella lab is supported by the MINECO (BFU2012-39151).-
dc.publisherFrontiers Media-
dc.relation.isversionofPublisher's version-
dc.rightsopenAccess-
dc.subjectEMT-
dc.subjectReporter-
dc.subjectPluripotency-
dc.subjectBreast cancer stem cell-
dc.subjectSox2-
dc.titleThe activation of the Sox2 RR2 pluripotency transcriptional reporter in human breast cancer cell lines is dynamic and labels cells with higher tumorigenic potential-
dc.typeartículo-
dc.identifier.doi10.3389/fonc.2014.00308-
dc.relation.publisherversionhttp://dx.doi.org/10.3389/fonc.2014.00308-
dc.date.updated2016-07-07T11:04:44Z-
dc.description.versionPeer Reviewed-
dc.language.rfc3066eng-
dc.rights.licensehttp://creativecommons.org/licenses/by/4.0/-
dc.contributor.funderMinisterio de Economía y Competitividad (España)-
dc.contributor.funderObra Social Kutxa-
dc.contributor.funderInstituto de Salud Carlos III-
dc.contributor.funderEusko Jaurlaritza-
dc.relation.csic-
dc.identifier.funderhttp://dx.doi.org/10.13039/501100003329es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100004587es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100003086es_ES
dc.identifier.pmid25414831-
dc.type.coarhttp://purl.org/coar/resource_type/c_6501es_ES
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextopen-
item.openairetypeartículo-
item.fulltextWith Fulltext-
Aparece en las colecciones: (IBMCC) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato
Tumorigenic Potential.pdf1,89 MBAdobe PDFVista previa
Visualizar/Abrir
Show simple item record

CORE Recommender

PubMed Central
Citations

14
checked on 11-abr-2024

SCOPUSTM   
Citations

16
checked on 28-abr-2024

Page view(s)

222
checked on 05-may-2024

Download(s)

252
checked on 05-may-2024

Google ScholarTM

Check

Altmetric

Altmetric


Artículos relacionados:


Este item está licenciado bajo una Licencia Creative Commons Creative Commons